DETROIT & ROYSTON, U.K., July 11, 2017 /EINPresswire.com/ — Asterand Bioscience, the leader in high quality, well-characterized human tissue and human tissue-based research solutions supporting drug discovery […]

Recent Data on Curetis’ Unyvero ITI Application Demonstrate its Clinical and Health Economic Benefits – Several ECCMID 2017 presentations highlight advantages of rapid time to result […]

Epigenomics Agrees to Takeover Bid Apr 26, 2017  NEW YORK (GenomeWeb) – German molecular diagnostics firm Epigenomics announced today that it has agreed to a public […]

Curetis’ Unyvero Intra-Abdominal Infection (IAI) Cartridge Receives CE Marking – Product to launch in EMEA at ECCMID Conference April 22-25, 2017 – IAI Panel covers up […]

Curetis to Present Data from Unyvero LRT U.S. FDA Clinical Trial at ASM Microbe – U.S. data set complemented by recent clinical study data from European […]

  FDA Approves 23andMe’s Genetic Test for Personal Disease Risks – Agency stresses that product labeling should show test not designed to diagnose, determine treatment or […]

Curetis Starts Subsidiary Ares Genetics to Advance Genetic Antibiotic Resistance Testing – Successful completion of GEAR asset and know how transfer from Siemens to Curetis Amsterdam, […]

Computational Biologists Predict Antibiotic Resistances Using Biotech March 10, 2017 06:47 ET | Source: Curetis GmbH Every year, some 25,000 people die in the European Union […]

U.S. Department of Veterans Affairs Awards Supply Contract for Epi proColon Berlin (Germany) and Germantown, MD (U.S.A.), March 3, 2017 – Epigenomics AG (Frankfurt Prime Standard: […]